PayGround, a healthcare fintech payments platform, today announced closing a $19.7M oversubscribed Series A financing led by SixThirty with participation from Rally Ventures, IA Capital Group, FCA Venture Partners and Plug and Play Ventures. The funding will bolster the company's rapid expansion into hospitals and health systems, building on its success in the ambulatory market, as well as grow its senior leadership team.

SafeRide Health, the leading technology-first platform connecting patients to life sustaining care, announced today the close of their Series B. SafeRide’s Series B is led by Sands Capital, a global asset manager with over $80 billion under management, with additional participation from new investors Seminal Capital, Hill City Capital, Fry’s Path Capital and Primetime Partners, as well as existing investors Fresenius Medical Ventures, Bonfire Ventures and Meridian Street Capital.

SafeRide Health, the leading technology-first platform connecting patients to life sustaining care, announced today the close of their Series B. SafeRide’s Series B is led by Sands Capital, a global asset manager with over $80 billion under management, with additional participation from new investors Seminal Capital, Hill City Capital, Fry’s Path Capital and Primetime Partners, as well as existing investors Fresenius Medical Ventures, Bonfire Ventures and Meridian Street Capital.

Vivante Health, the leader in digital digestive health, today announced the closing of $31 million in Series B funding led by new investor Mercato Partners. The round also includes new capital from Health Catalyst Capital as well as returning investors 7wireVentures, Intermountain Ventures, Distributed Ventures, Human Capital, and SemperVirens.

evolvedMD, the market leader in delivering integrated Collaborative Care Management (CoCM) services in primary care, has raised a $14 million Series-A Prime round led by San Francisco-based Conductive Ventures with additional investment from FCA Venture Partners, Healthworx, Tectonic Ventures and Waterline Ventures.

Diligent Pharma Inc, a private vendor qualification and risk management organization, offering a centralized technology platform for streamlining vendor qualification in clinical trial execution announced today, the closing of an $8.27 Million Series A financing round led by FCA Venture Partners.

Intrinsic, an omni-channel consumer health company, today announced a $15 million equity fundraise to focus exclusively on women's health. The new capital, which brings the company's total funding to $128 million raised to date, includes participation from new investors FCA Venture Partners and MAP Investco, along with existing investors Define Ventures, Link Ventures, Redesign Health, and others.